🇺🇸 FDA
Pipeline program

NKTR-358, Sodium Chloride 0.9% solution

23-358-05

Phase 2 small_molecule active

Quick answer

NKTR-358, Sodium Chloride 0.9% solution for Atopic Dermatitis is a Phase 2 program (small_molecule) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Nektar Therapeutics UK Limited
Indication
Atopic Dermatitis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials